CAS.NO: 844439-96-9

Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia.

Insulin Degludec Injection Specifications

Product Name Insulin Degludec

Packing Specification 10g/100g/500g

Appearances White or off-white powder

Activity: NLT 10Unit/mg NLT 10Unit/mg

Content: 95.0%~105.0% 95.0%~105.0%

Bacterial Endotoxin Less than 10 EU/mg

Residual HCP NMT 10ng/mg

Residual Exogenous DNA NMT 10ng/dose

Macromolecular Potein NMT 0.4%

HPLC Purity ＞99.0%

Storage Conditions -15℃ below, protected from light, sealed

The data should be subject to test report of products.

Insulin Degludec Recommended Method

Insulin Degludec easy dissolved in acidic (pH<2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.

Insulin Degludec Transport and Storage Stability

Transportation stability: It is transported in an ice pack to keep it active.

Storage stability: The product can be stored for at least 24 months at -15°C below.

Notice and Disclaimer

Pollution should be avoided during operation.

The product should not be used for diagnosis or treatment of animals or humans.

Now the insulin degludec cost, insulin degludec price is reasonable, if you have needs, please contact us.

If you want to know more about insulin degludec uses and insulin degludec duration of action, please visit our website.

Gene Biocon, as a professional biological pharmaceutical manufacturer in R&D Bio-pharmaceutical raw material, we have committed to research and development of biological pharmacy raw materials for the treatment of type I and II diabetes and weight loss. Mainly include:Insulin Degludec, Insulin Aspart, Liraglutide and Semaglutide.